Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 6 Tabular representation of number of isolates showing synergism in association with the molecular resistance mechanisms among LR-MRSA isolates

From: Phenotypic and genotypic characterization of linezolid resistance and the effect of antibiotic combinations on methicillin-resistant Staphylococcus aureus clinical isolates

Synergistic combinations

Number of LR-MRSA isolates showing synergism

Number of isolates showing resistance genotype

Domain V region of 23 S rRNA mutations

rplC gene (L3) mutations

rplD gene (L4) mutations

cfr(B)

icaA

mecA

LZD—CHL

5

4

3

2

2

3

3

LZD—GEN

3

2

2

1

3

2

2

LZD—ERY

5

4

3

2

3

4

4

LZD—VAN

3

3

2

1

1

3

3

LZD—CIP

5

4

3

2

1

3

3